Codiak BioSciences, Inc. Operating Cash Flow
Codiak BioSciences, Inc. reported Operating Cash Flow of -$45.56 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-03
- Codiak BioSciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$10.11M.
- Codiak BioSciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$14.60M.
- Codiak BioSciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$20.85M.
- Codiak BioSciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$21.52M.
- Codiak BioSciences, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$74.14M.
- Codiak BioSciences, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$63.36M.
- Codiak BioSciences, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$1.70M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$10.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$24.71M derived: sum of 2 quarters · filed 2022-11-03 | -$45.56M 10-Q · filed 2022-11-03 | -$67.08M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | -$14.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$35.45M 10-Q · filed 2022-08-04 | -$56.97M derived: sum of 3 quarters · filed 2022-08-04 | -$72.27M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$20.85M 10-Q · filed 2022-05-05 | -$42.37M derived: sum of 2 quarters · filed 2022-05-05 | -$57.67M derived: sum of 3 quarters · filed 2022-11-03 | -$75.36M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | -$21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$36.82M derived: sum of 2 quarters · filed 2022-11-03 | -$54.51M derived: sum of 3 quarters · filed 2022-11-03 | -$74.14M 10-K · filed 2022-03-10 |
| 2021-09-30 | -$15.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$32.98M derived: sum of 2 quarters · filed 2022-11-03 | -$52.62M 10-Q · filed 2022-11-03 | -$86.49M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$17.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$37.32M 10-Q · filed 2022-08-04 | -$71.19M derived: sum of 3 quarters · filed 2022-08-04 | -$86.23M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$19.64M 10-Q · filed 2022-05-05 | -$53.51M derived: sum of 2 quarters · filed 2022-05-05 | -$68.55M derived: sum of 3 quarters · filed 2022-05-05 | -$64.01M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$33.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$48.91M derived: sum of 2 quarters · filed 2022-03-10 | -$44.37M derived: sum of 3 quarters · filed 2022-03-10 | -$63.36M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$15.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$10.50M derived: sum of 2 quarters · filed 2021-11-04 | -$29.49M 10-Q · filed 2021-11-04 | -$44.11M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$14.45M 10-Q · filed 2021-08-05 | -$29.07M derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$18.99M 10-Q · filed 2021-05-06 | -$33.61M derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | -$14.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$1.70M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $12.92M 10-Q · filed 2020-11-19 |